Rama Phosphates Q1 FY27: Record operating revenue, steady profit, and capacity builds that matter
Ask Iris
Frequently Asked Questions
It covers the quarter ended June 30, 2026, presented as Q1 FY27.
Revenue from operations was INR 224.80 crore, EBITDA was INR 28.65 crore, and PAT was INR 17.06 crore.
Revenue from operations increased 18% year-on-year from INR 190.31 crore to INR 224.80 crore, while PAT increased 6% from INR 16.03 crore to INR 17.06 crore.
The company cited record turnover and EBITDA, focus on value added products, and noted input cost pressures due to a 15 to 20% rise in key raw material prices linked to the West Asia conflict, which it stated was passed on to customers.
The presentation highlights the Dhule new plant project with Phase 1 trial production targeted in Q2 FY 2026-27 and mentions the Udaipur new plant project progressing on schedule.
The presentation mentions Girnar and Suryafull, and also shows product brands Bharat NPK (Urea SSP), Sampurn, and Sampurn +MG.
It states an ambition to become a 2000+ crore turnover company with focus on chemicals and fertilizers, expand into complex P&K, NPK and DAP manufacturing, and scale SSP leadership across India.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
